Trigeminal neuralgia (TN), also called "tic douloureux", is the most common form of craniofacial neuropathic pain and is considered the cause of one of the most painful afflictions known in medical practice. This study is designed to evaluate the efficacy and safety of 1.5mg - 3.5mg basimglurant in adults with TN.
Trigeminal Neuralgia
Trigeminal neuralgia (TN), also called "tic douloureux", is the most common form of craniofacial neuropathic pain and is considered the cause of one of the most painful afflictions known in medical practice. This study is designed to evaluate the efficacy and safety of 1.5mg - 3.5mg basimglurant in adults with TN.
An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients with Trigeminal Neuralgia.
-
Kaizen Brain Center (Site #: 1001), La Jolla, California, United States, 92037
University of South Florida (Site #: 1002), Tampa, Florida, United States, 33612
Beth Israel Deaconess Medical Center (Site #: 1004), Boston, Massachusetts, United States, 02215
Altea Research - Nevada - ClinEdge - PPDS (Site #1006), Las Vegas, Nevada, United States, 89102-1972
Columbia University - Irving Medical Center (Site #: 1008), New York, New York, United States, 10032
University of Cincinnati (Site #: 1007), Cincinnati, Ohio, United States, 45219
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to 75 Years
ALL
No
Noema Pharma AG,
2026-01-31